Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression

BACKGROUND/AIM: Sorafenib leads to improved survival in advanced hepatocellular carcinoma (HCC) patients. Continuation of sorafenib beyond progression has been a possible treatment strategy when further approved therapeutic agents are lacking. METHODS: We performed a retrospective analysis of all HC...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Gastrointest Tumors
Autori principali: Apostolidis, Leonidas, Pfeiffenberger, Jan, Gotthardt, Daniel, Radeleff, Boris, Mehrabi, Arianeb, Schemmer, Peter, Jäger, Dirk, Schirmacher, Peter, Stremmel, Wolfgang, Schulze-Bergkamen, Henning, Springfeld, Christoph, Weiss, Karl Heinz
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger AG 2018
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6288626/
https://ncbi.nlm.nih.gov/pubmed/30574480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487635
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi